Alice Ke

1.2k citations
30 papers · 755 indexed · h-index 16
Topics
Pharmacogenetics and Drug Metabolism (10 papers)Drug Transport and Resistance Mechanisms (8 papers)Pharmacological Effects and Toxicity Studies (6 papers)

In The Last Decade

Alice Ke

29 papers receiving 741 citations

Peers

Alice Ke
Comparison fields: 5 of 88
  • Pediatrics, Perinatology and Child Health 240
  • Pharmacology 228
  • Oncology 208
  • Public Health, Environmental and Occupational Health 200
  • Molecular Biology 138
Replace Juri Solodenko with:
Juri Solodenko Germany
Mohamad Shebley United States
Songmao Zheng United States
Xian Pan United Kingdom
Inna Y. Gong Canada
Vikram Arya United States
Mariana Rodrigues Botton Brazil
George W. Mihaly Australia
Maarten T. Huisman Netherlands
Alice Ke relative to Juri Solodenko Germany Juri Solodenko's profile →
Citations per field
00.5×3.8×
Juri Solodenko · 1×
Citations per year

Countries citing papers authored by Alice Ke

Since Specialization
Citations

This map shows the geographic impact of Alice Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Ke more than expected).

Fields of papers citing papers by Alice Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Ke. The network helps show where Alice Ke may publish in the future.

Co-authorship network of co-authors of Alice Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Ke. A scholar is included among the top collaborators of Alice Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Ke. Alice Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 6
5 32
6 19
7 7
8 12
9 53
10 1
11 44
12 14
13 16
14 16
15 50
16 65
17 71
18 82
19 26
20 75

About Alice Ke

Alice Ke is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Family Practice, having authored 30 papers that have together received 755 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). The work is most often cited by research in Pharmacology (228 citations), Obstetrics and Gynecology (98 citations) and Pediatrics, Perinatology and Child Health (240 citations). Alice Ke has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Jashvant D. Unadkat, Amin Rostami‐Hodjegan, Ping Zhao, J. William Higgins, Srikanth C. Nallani, Maciej J. Zamek‐Gliszczynski, Khaled Abduljalil, Rick Greupink, Mark A. Milad and Lisa M. Almond. Their work appears in journals such as Blood, Neurology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026